• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    2/10/23 4:29:02 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $VHAQ alert in real time by email
    SC 13G/A 1 Viveon.txt Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No._1)* (Name of Issuer) Viveon Health Acquisition Corp (Title of Class of Securities) Common Stock (CUSIP Number) Viveon Health Acquisition Corp (Date of Event Which Requires Filing of this Statement) 12/31/2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. 92853V106 (1) Names of reporting persons Polar Asset Management Partners Inc. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Citizenship or place of organization Ontario, Canada Number of shares beneficially owned by each reporting person with: (5) Sole voting power 650,000 (6) Shared voting power (7) Sole dispositive power 650,000 (8) Shared dispositive power (9) Aggregate amount beneficially owned by each reporting person 650,000 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 9.45% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: Viveon Health Acquisition Corp Item 1(b) Address of issuer's principal executive offices: c/o Gibson, Deal & Fletcher, PC Spalding Exchange 3953 Holcomb Bridge Road Suite 200 Norcross Georgia, 30092 2(a) Name of person filing: This statement is filed by Polar Asset Management Partners Inc., a company incorporated under the laws of Ontario, Canada, which serves as the investment advisor to Polar Multi-Strategy Master Fund, a Cayman Islands exempted company ("PMSMF") with respect to the Shares (as defined below) directly held by PMSMF. 2(b) Address or principal business office or, if none, residence: 16 York Street, Suite 2900, Toronto, ON, Canada M5J 0E6. 2(c) Citizenship: Canada 2(d) Title of class of securities: Common Stock 2(e) CUSIP Number: 92853V106 Item 3. [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); [x] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: The Reporting Person is an investment fund manager, portfolio manager, exempt market dealer and commodity trading manager registered with the Ontario Securities Commission. Item 4. Ownership As of December 31, 2022 1. Polar Asset Management Partners (a) Amount beneficially owned: 650,000 (b) Percent of class: 9.45% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 650,000 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 650,000 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5.Ownership of 5 Percent or Less of a Class. Not applicable Item 6. Ownership of More than 5 Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below I certify that, to the best of his/her knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 10, 2023 POLAR ASSET MANAGEMENT PARTNERS INC. By: /s/ Andrew Ma Name: Andrew Ma Title: Chief Compliance Officer
    Get the next $VHAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VHAQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VHAQ
    SEC Filings

    View All

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/19/24 5:01:10 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Viveon Health Acquisition Corp.

    8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    7/19/24 5:00:45 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by Viveon Health Acquisition Corp.

    25-NSE - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/10/24 9:51:56 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success

    San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey Coleman for his services as a Board Member to Clearday since its merger back in September 2021. James Walesa, CEO and Founder of Clearday, said, "Jeff has been a staunch supporter of the cause of innovating Senior Care for years. He has brought wisdom and experience to our Board over the last three (3) years. We know Jeff will be an asset to his next company. We wish him well in his new endeavors and feel confident that he will be met with great success." Clearday seeks

    5/2/24 2:15:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS

    New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. The Company is focused on completing all of its regulatory filings to support completing the business combination with Clearday. Additionally, the Company will be appealing the recent decision by a hearings panel of the NYSE American's Committee for Review confirming the decision by the NYSE Staff to delist the Company's units, common stock and rights. As a result of that decisi

    2/27/24 4:45:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION

    Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") today is pleased to reconfirm its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. Clearday's mission is to bring digital companionship to the 170 million Americans turning 50 by 2030. The companies, together with their financial advisor, ClearThink Capital, have been working diligently on the transaction and look forward to continuing to work with ClearThink after the propose

    2/1/24 9:30:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Logothetis Demetrios G.

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/4/21 3:45:58 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: Viveon Health, LLC decreased direct ownership by 0.55% to 4,923,250 units

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/3/21 5:47:20 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3: Logothetis Demetrios G. claimed no ownership of Common Stock

    3 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    5/12/21 8:38:37 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $VHAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 4:56:17 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 1:18:24 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/12/24 11:08:50 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care